Emerging Infectious Diseases (Feb 2019)

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12–19 Months after Illness Onset

  • Isabel Griffin,
  • Stacey W. Martin,
  • Marc Fischer,
  • Trudy V. Chambers,
  • Olga Kosoy,
  • Alyssa Falise,
  • Olga Ponomareva,
  • Leah D. Gillis,
  • Carina Blackmore,
  • Reynald Jean

DOI
https://doi.org/10.3201/eid2502.181286
Journal volume & issue
Vol. 25, no. 2
pp. 299 – 303

Abstract

Read online

Data on the duration of detectable Zika virus–specific IgM in infected persons are limited. Neutralizing antibody cross-reactivity occurs between Zika virus and related flaviviruses, but the degree to which this confounds diagnosis is uncertain. We tested serum specimens collected 12–19 months after illness onset from patients with confirmed Zika virus disease for Zika virus IgM and Zika virus and dengue virus neutralizing antibodies. Among 62 participants, 45 (73%) had detectable Zika virus IgM and 12 (19%) had an equivocal result. Although all patients tested had Zika virus neutralizing antibodies, 39 (63%) also had neutralizing antibodies against dengue virus; of those, 12 (19%) had 4-fold higher than Zika virus titer. Prolonged detection of IgM and neutralizing antibody cross-reactivity make it difficult to determine the timing of Zika virus infection and differentiate between related flaviviruses.

Keywords